Showing 2131-2140 of 9096 results for "".
Vanquish Approved for Circumferential Fat Reduction; Acquisition News
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-vanquish-approved-for-circumferential-fat-reduction-acquisition-news/18884/BTL's Vanquish Cleared for Circumferential Fat Reduction of the Abdomen, Filler Injections Gain Popularity Off the Face, Protein Linked to Aggressive Melanomas, and new acquisitions at Kythera, Lumenis, XTRAC.ASDS BCC Recommendations; Bad Online Reviews for Derms
https://practicaldermatology.com/topics/practice-management/dermwiretv-asds-bcc-recommendations-bad-online-reviews-for-derms/18906/This edition of DermWireTV, from the editors of Practical Dermatology® magazine reviews the new ASDS Consensus Recommendation for the management of Basal Cell Carcinoma (BCC). An expert panel found Mohs micrographic surgery is highly cost effective. In other news, researchers find that dermatologistKythera's Kybella Approved; ASLMS Update
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-kythera-s-kybella-approved-aslms-update/18925/FDA Approves Kythera's Kybella (ATX-101 or deoxycholic acid) injection for reduction of sub mental fullness or double chin. ASLMS Recognizes women in device-based medicine (Women in Energy-based Devices). Deka and Syneron get new clearances. ASDS Launches Skin Cancer PSAs, and Foamix sells shares.Atopic Dermatitis Guidelines Update
https://practicaldermatology.com/topics/general-topics/atopic-dermatitis-guidelines-update/18949/Peter Lio, MD speaks with Joel Cohen, MD about atopic dermatitis consensus recommendations, particularly the differences among different medical specialties. He also discusses how global guidelines may begin to take shape.Valeant Acquires Salix; Actavis Changing Name
https://practicaldermatology.com/videos/dermwire-tv/valeant-acquires-salix-actavis-changing-name/18963/Valeant expands its portfolio with the acquisition of GI market leader Salix. Actavis divests Doryx and considers a name change to Allergan. Kythera acquires rights for investigational hair therapies. And Cynosure's 532nm laser delivery system is FDA cleared for PicoSure.2014 Year in Review: Skin Cancer
https://practicaldermatology.com/topics/skin-cancer-photoprotection/2014-year-in-review-skin-cancer/19001/Gary Goldenberg, MD offers a snapshot look at the newest therapies in the skin cancer treatment landscape, as well as the newest innovations across various disease states in the specialty.Periorbital Rejuvenation Trends
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/periorbital-rejuvenation-trends/19046/Brian Biesman, MD talks about assessment of the aging face and approaches for periorbital rejuvenation.Allergan Strikes $66 Billion Deal with Actavis
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-allergan-strikes-66-billion-deal-with-actavis/19021/In this edition of DermWireTV, host Ranna Jaraha discusses this week's blockbuster merger deal between Allergan and Actavis. Also featured in this edition is a new report detailing the rising costs of treating skin cancer, and high recognition for a dermatologic device manufacturer.Acquiring An Education In Cosmetic Dermatology
https://practicaldermatology.com/topics/practice-management/acquiring-an-education-in-cosmetic-dermatology/19024/With many residency programs not emphasizing cosmetic dermatology, Kristina Goldenberg, MD gives advice on how to be proactive in achieving an education in aesthetics.No One Right Way to Treat a Patient
https://practicaldermatology.com/topics/practice-management/no-one-right-way-to-treat-a-patient/19026/Recounting experiences in residency, Kristina Goldenberg, MD talks about the importance of synthesizing various approaches and styles of practice from mentors.